Prevalence of chronic obstructive pulmonary disease (COPD) in China in 1990 and 2010

被引:89
作者
Chan, Kit Yee [1 ,2 ]
Li, Xue [1 ]
Chen, Wanjing [1 ,3 ,4 ]
Song, Peige [1 ]
Wong, Nuen Wing Katy [1 ,5 ]
Poon, Adrienne N. [1 ,6 ]
Jian, Wenyan [7 ]
Soyiri, Ireneous Y. [8 ]
Cousens, Simon [9 ]
Adeloye, Davies [1 ,10 ]
Sheikh, Aziz
Campbell, Harry [1 ]
Rudan, Igor [1 ]
机构
[1] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Ctr Global Hlth Res, Teviot Pl, Edinburgh EH8 9AG, Midlothian, Scotland
[2] Univ Melbourne, Nossal Inst Global Hlth, Melbourne, Vic, Australia
[3] Sichuan Acad Med Sci, Chengdu, Sichuan, Peoples R China
[4] Sichuan Prov Peoples Hosp, Chengdu, Sichuan, Peoples R China
[5] Hosp Author, Hong Kong, Hong Kong, Peoples R China
[6] George Washington Univ, Sch Med & Hlth Sci, Dept Internal Med, Washington, DC 20052 USA
[7] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Hlth Policy & Management, Beijing, Peoples R China
[8] Univ Edinburgh, Ctr Med Informat, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland
[9] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Keppel St, London, England
[10] Covenant Univ, Demog & Social Stat & E Hlth Res Cluster, Ota, Ogun State, Nigeria
关键词
AMBIENT AIR-POLLUTION; GLOBAL BURDEN; HEALTH; EPIDEMIOLOGY; SMOKING; TRENDS; DISABILITY; KADOORIE; GENDER; COSTS;
D O I
10.7189/jogh.07.020704
中图分类号
R1 [预防医学、卫生学];
学科分类号
100235 [预防医学];
摘要
Background Chronic obstructive pulmonary disease (COPD) is set to become the third most frequent cause of death and also the third largest cause of global morbidity by 2020. In China, where the population is aging rapidly, COPD has become one of the leading causes of disability and a large economic burden. An epidemiological assessment of the COPD in China is required, with a focus on the number of cases living with disease, main determinants of the disease and time trends. Methods. We systematically searched large Chinese bibliographic databases and English databases to identify spirometry-based epidemiological studies of the prevalence of COPD in China diagnosed according to GOLD criteria. We estimated age-and gender-specific prevalence of COPD using a multilevel mixed-effect logistic regression. We also presented the time trends of COPD between 1990 and 2010 by age, gender and setting (urban vs rural). Findings In 1990, the prevalence of COPD ranged from 0.49% (95% CI = 0.29-0.85) in < 20 years group to 20.95% (95% CI = 14.04-27.04) in> = 80 years group, and the crude prevalence for China was 2.70% (95% CI = 1.86-3.51). In 2010, the prevalence in < 20 years was 0.55% (95% CI = 0.37-1.04) and in> = 80 years was 22.89% (95% CI = 18.13-28.96), with the crude prevalence for China of 3.84% (95% CI = 3.30-4.77). The COPD prevalence in males was about two-fold higher than in females, and it increased with increasing age. Between 19902010, the total number of Chinese people living with COPD increased by 66.73%, from 30.90 million (95% CI = 21.28-40.02) in 1990 to 51.52 million (95% CI = 44.26-63.93) in 2010. This increase was most striking in middle age, and greater in females than in males from 30 years up to 64 years. Our estimates, which used an independent approach to acquiring data and development of analytical methods, and were based on a more complete data set, are remarkably similar to those produced recently by the GBD 2013 collaboration, differing by only about 5% in the estimated number of COPD cases in 1990 and by 1% in 2010. Conclusions COPD is a highly prevalent disease in China and its importance is growing steadily. The number of people living with COPD has increased substantially between 1990 and 2010. COPD is more frequent in males and in rural areas. Optimised primary and secondary prevention and treatment is urgently needed to counter this growing trend. Improved epidemiological studies will be required to assist development of more effective strategies of prevention and treatment of COPD in China in the next decade and beyond.
引用
收藏
页数:11
相关论文
共 53 条
[1]
Global and regional estimates of COPD prevalence: Systematic review and meta-analysis [J].
Adeloye, Davies ;
Chua, Stephen ;
Lee, Chinwei ;
Basquill, Catriona ;
Papana, Angeliki ;
Theodoratou, Evropi ;
Nair, Harish ;
Gasevic, Danijela ;
Sridhar, Devi ;
Campbell, Harry ;
Chan, Kit Yee ;
Sheikh, Aziz ;
Rudan, Igor .
JOURNAL OF GLOBAL HEALTH, 2015, 5 (02) :186-202
[2]
Systemic effects of chronic obstructive pulmonary disease [J].
Agustí, AGN ;
Noguera, A ;
Sauleda, J ;
Sala, E ;
Pons, J ;
Busquets, X .
EUROPEAN RESPIRATORY JOURNAL, 2003, 21 (02) :347-360
[3]
[4]
Random effects structure for testing interactions in linear mixed-effects models [J].
Barr, Dale J. .
FRONTIERS IN PSYCHOLOGY, 2013, 4
[5]
International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study [J].
Buist, A. Sonia ;
McBurnie, Mary Ann ;
Vollmer, William M. ;
Gillespie, Suzanne ;
Burney, Peter ;
Mannino, David M. ;
Menezes, Ana M. B. ;
Sullivan, Sean D. ;
Lee, Todd A. ;
Weiss, Kevin B. ;
Jensen, Robert L. ;
Marks, Guy B. ;
Gulsvik, Amund ;
Nizankowska-Mogilnicka, Ewa .
LANCET, 2007, 370 (9589) :741-750
[6]
Celli Bartolome R., 2000, Chest, V117, p15S, DOI 10.1378/chest.117.2_suppl.15S
[7]
Epidemiology and costs of chronic obstructive pulmonary disease [J].
Chapman, KR ;
Mannino, DM ;
Soriano, B ;
Vermeire, PA ;
Buist, AS ;
Thun, MJ ;
Connell, C ;
Jemal, A ;
Lee, TA ;
Miravitlles, M ;
Aldington, S ;
Beasley, R .
EUROPEAN RESPIRATORY JOURNAL, 2006, 27 (01) :188-207
[8]
China Kadoorie Biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-up [J].
Chen, Zhengming ;
Chen, Junshi ;
Collins, Rory ;
Guo, Yu ;
Peto, Richard ;
Wu, Fan ;
Li, Liming .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2011, 40 (06) :1652-1666
[9]
Cohort profile: The Kadoorie study of chronic disease in China (KSCDC) [J].
Chen, ZM ;
Lee, L ;
Chen, JS ;
Collins, R ;
Wu, F ;
Guo, Y ;
Linksted, P ;
Peto, R .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2005, 34 (06) :1243-1249
[10]
Chronic obstructive pulmonary disease and comorbidities [J].
Decramer, Marc ;
Janssens, Wim .
LANCET RESPIRATORY MEDICINE, 2013, 1 (01) :73-83